首页> 外国专利> METHOD OF DIAGNOSING CANCER, PRECANCEROUS STATE, OR SUSCEPTIBILITY TO OTHER FORMS OF DISEASES BY ANALYSIS OF IRF-1-SPECIFIC RNA IN BIOPSY SAMPLES

METHOD OF DIAGNOSING CANCER, PRECANCEROUS STATE, OR SUSCEPTIBILITY TO OTHER FORMS OF DISEASES BY ANALYSIS OF IRF-1-SPECIFIC RNA IN BIOPSY SAMPLES

机译:通过分析活检样本中IRF-1特异性RNA诊断癌症,癌前状态或对其他疾病的敏感性的方法

摘要

The present invention relates to a method of diagnosing cancer, precancerous state, and susceptibility to other forms of diseases, by use of a molecular marker, interferon-regulatory factor-1 (IRF-1). The method is characterized in that IRF-1-specific RNA is analysed in a sample obtained from blood or other biopsy material, preferably by reverse transcrip-tion/polymerase chain reaction. The invention is based on the unexpected finding that a novel mechanism of inactiva-tion of the tumor suppressor gene IRF-1 plays a crucial role e.g. in hematopoietic malignancies. An unusual exon skipping leads to RNA molecules which lack exon 2 or exons 2 and 3. The relative amounts of full-length RNA and shortened RNA molecules are significantly different in samples obtained from tumor patients as compared to healthy donors.
机译:本发明涉及通过使用分子标志物干扰素调节因子-1(IRF-1)诊断癌症,癌前状态和对其他形式疾病的易感性的方法。该方法的特征在于,优选通过逆转录/聚合酶链反应,对从血液或其他活检材料获得的样品中的IRF-1特异性RNA进行分析。本发明基于出乎意料的发现,即抑癌基因IRF-1的失活的新机制起着至关重要的作用,例如,抗肿瘤作用。在造血系统恶性肿瘤中。不常见的外显子跳跃导致缺少外显子2或外显子2和3的RNA分子。与健康供体相比,从肿瘤患者获得的样品中全长RNA和缩短的RNA分子的相对量显着不同。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号